Axsome Therapeutics to Participate in Upcoming Investor Conferences Feb 25, 2026 07:00AM
Axsome Therapeutics (AXSM) PT Raised to $215 at TD Cowen Feb 23, 2026 12:17PM
TD Cowen on Axsome Therapeutics (AXSM): 'the sNDA acceptance should be well received by investors' Dec 31, 2025 08:24AM
Axsome Therapeutics to Participate in Upcoming Investor Conferences Aug 27, 2025 07:00AM
Axsome Therapeutics to Participate in Upcoming Investor Conferences Feb 26, 2025 07:00AM


Feb 11, 2025 05:25AM Axsome Therapeutics (AXSM) PT Raised to $190 at TD Cowen, Top Pick
Jan 29, 2025 07:08AM Axsome Therapeutics (AXSM) PT Raised to $155 at TD Cowen
Sep 16, 2024 08:43AM TD Cowen Reiterates Buy Rating on Axsome Therapeutics (AXSM)
Feb 27, 2024 07:00AM Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Dec 5, 2023 08:22AM Axsome Therapeutics (AXSM) Named Best 2024 Idea at TD Cowen
Sep 5, 2023 07:00AM Axsome Therapeutics to Present at Three Upcoming Investor Conferences
Mar 1, 2023 07:00AM Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
Mar 1, 2023 07:00AM Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
Sep 14, 2022 07:00AM Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
Sep 14, 2022 07:00AM Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
Aug 19, 2022 10:39AM Cowen Reiterates Outperform, $130 PT on Axsome Therapeutics (AXSM) Following FDA Approval
Jun 29, 2022 09:33AM Axsome Therapeutics (AXSM) PT Raised to $130 at Cowen
Jun 1, 2022 09:00AM Cowen Reiterates Outperform Rating on Axsome Therapeutics (AXSM), Analyst Remains Optimistic for Approval of AXS-05, Sees 100-125% Upside
Mar 2, 2022 07:00AM Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
Mar 2, 2022 07:00AM Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
Jan 18, 2022 08:55AM Axsome Therapeutics' (AXSM) Recent FDA Communications Are Encouraging Signs of Progress, Reiterate Overweight - Cowen
Aug 23, 2021 12:58PM Cowen Maintains Positive View on Axsome Therapeutics (AXSM) Despite PDUFA Delay
Aug 9, 2021 01:33PM Axsome Therapeutics's (AXSM) AXS-05 Deficiencies Set Stage for Near-Term CRL - Analyst
Aug 9, 2021 11:20AM Axsome Therapeutics (AXSM) PT Lowered to $125 at Cowen
Feb 19, 2021 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Feb 19, 2021 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Apr 27, 2020 11:54AM Axsome Therapeutics (AXSM) PT Raised to $135 at Cowen
Apr 14, 2020 05:31AM Cowen Starts Axsome Therapeutics (AXSM) at Outperform
Feb 19, 2020 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Feb 19, 2020 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Jan 9, 2018 09:31AM Pre-Open Movers 01/09: (ATUS) (PSTI) (GBT) Higher; (AXSM) (BGFV) (D) Lower (more...)